International Journal of Hygiene and Environmental Health,
Journal Year:
2024,
Volume and Issue:
259, P. 114382 - 114382
Published: April 22, 2024
Air
pollution
is
a
known
risk
factor
for
several
diseases,
but
the
extent
to
which
it
influences
COVID-19
compared
other
respiratory
diseases
remains
unclear.
We
performed
test-negative
case-control
study
among
people
with
COVID-19-compatible
symptoms
who
were
tested
SARS-CoV-2
infection,
assess
whether
their
long-
and
short-term
exposure
ambient
air
(AAP)
was
associated
testing
positive
(vs.
negative)
SARS-CoV-2.
used
individual-level
data
all
adult
residents
in
Netherlands
between
June
November
2020,
when
only
symptomatic
tested,
modeled
concentrations
of
PM10,
PM2.5,
NO2
O3
at
geocoded
residential
addresses.
In
long-term
analysis,
we
selected
individuals
did
not
change
address
2017–2019
(1.7
million
tests)
considered
average
PM2.5
that
period,
different
sources
PM
(industry,
livestock,
agricultural
activities,
road
traffic,
Dutch
sources,
foreign
sources).
changing
two
weeks
before
day
(2.7
included
analyses,
thus
considering
1-
2-week
as
exposure.
Mixed-effects
logistic
regression
analysis
adjustment
confounders,
including
municipality
week
account
spatiotemporal
variation
viral
circulation,
used.
Overall,
there
no
statistically
significant
effect
studied
pollutants
on
odds
vs.
negative
However,
associations
PM10
from
specifically
livestock
observed.
Short-term
(adjusting
NO2)
also
positively
increased
While
these
exposures
seemed
increase
relative
underlying
biological
mechanisms
remain
This
reinforces
need
continue
strive
better
quality
support
public
health.
Journal of Antimicrobial Chemotherapy,
Journal Year:
2024,
Volume and Issue:
79(11), P. 2887 - 2895
Published: Aug. 13, 2024
Abstract
Background
The
antiviral
efficacy
of
Evusheld
(AZD7442)
in
patients
hospitalized
for
SARS-CoV-2
is
unknown.
Methods
We
analysed
the
evolution
both
nasopharyngeal
viral
load
and
serum
neutralization
activity
against
variant
infection
199
(109
treated
with
Evusheld,
90
placebo)
infected
virus
included
randomized,
double-blind,
trial
DisCoVeRy
(NCT04315948).
Using
a
mechanistic
mathematical
model,
we
reconstructed
trajectories
kinetics
how
they
are
modulated
by
increase
during
treatment.
Results
Our
model
identified
that
was
associated
kinetics.
Reflecting
variant-dependent
larger
pre-Omicron
or
Omicron
BA.2
variants
than
BA.1
variant.
More
specifically,
predicted
reduced
median
time
to
clearance
compared
placebo-treated
more
5
days
(median:
5.9;
80%
PI:
2.1–13.6)
5.4;
2.0–12.4),
respectively.
effect
modest
variant,
reducing
2
2.2;
0.4–8.9).
Conclusions
Hospitalized
had
shorter
clearance.
As
mediated
level
activity,
its
impact
on
varies
largely
according
infection.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Aug. 24, 2023
Abstract
In
a
pivotal
trial
(EPIC-HR),
5-day
course
of
oral
ritonavir-boosted
nirmatrelvir,
given
early
during
symptomatic
SARS-CoV-2
infection
(within
three
days
symptoms
onset),
decreased
hospitalization
and
death
by
89.1%
nasal
viral
load
0.87
log
relative
to
placebo
in
high-risk
individuals.
Yet,
nirmatrelvir/ritonavir
failed
as
post-exposure
prophylaxis
trial,
frequent
rebound
has
been
observed
subsequent
cohorts.
We
developed
mathematical
model
capturing
viral-immune
dynamics
nirmatrelvir
pharmacokinetics
that
recapitulated
loads
from
this
another
clinical
(PLATCOV).
Our
results
suggest
nirmatrelvir’s
vivo
potency
is
significantly
lower
than
vitro
assays
predict.
According
our
model,
maximally
potent
agent
would
reduce
the
approximately
3.5
logs
at
5
days.
The
identifies
earlier
initiation
shorter
treatment
duration
are
key
predictors
post-treatment
rebound.
Extension
10
for
Omicron
variant
vaccinated
individuals,
rather
increasing
dose
or
dosing
frequency,
predicted
incidence
significantly.
Scientific Data,
Journal Year:
2024,
Volume and Issue:
11(1)
Published: Jan. 24, 2024
Abstract
Here
we
provide
data
from
an
online
survey
of
639
people
diagnosed
with
COVID-19
and
resident
in
France,
who
were
between
30th
Jan
2020
29th
August
2022.
In
addition
to
demographic
information
the
includes
questions
about
participants’
symptoms
(by
category),
symptom
onset
persistence,
effects
these
had
on
their
daily
lives.
Participants
able
include
related
perceived
medical,
social
professional
needs.
These
are
needed
order
create
effective
care
policies
addressing
post-COVID
sequelae.
Information
association
&
dynamics
is
expected
be
useful
clinicians
may
also
inform
more
fundamental
studies.
Frontiers in Public Health,
Journal Year:
2024,
Volume and Issue:
12
Published: March 8, 2024
Background
SARS-CoV-2
strains
have
been
of
great
concern
due
to
their
high
infectivity
and
antibody
evasion.
Methods
In
this
study,
data
were
collected
on
indigenous
aggregated
outbreaks
in
Nanjing
from
January
2020
December
2022,
caused
by
five
including
the
original
strain,
Delta
variant,
Omicron
variant
(BA.2,
BA.5.2,
BF.7).
The
basic
epidemiological
characteristics
infected
individuals
described
then
parametric
analysis
transmission
dynamics
was
performed,
calculation
incubation
period,
serial
interval
(SI),
reproductive
number
(R
0
),
household
secondary
attack
rate
(HSAR).
Finally,
we
compared
trends
dynamic
parameters
different
strains.
Results
period
for
BA.2,
BF.7
6
d
(95%
CI:
3.5–7.5
d),
5
4.0–6.0
3
3.0–4.0
3.0–3.0
2
2.0–3.0
respectively;
Also,
SI
5.69
d,
4.79
2.7
2.12
2.43
respectively.
Notably,
had
both
a
progressive
shortening
trend
(
p
<
0.001);
Moreover,
R
2.39
1.30–4.29),
3.73
2.66–5.15),
5.28
3.52–8.10),
5.54
2.69–11.17),
7.39
2.97–18.76),
with
an
increasing
gradually
0.01);
HSAR
25.5%
20.1–31.7%),
27.4%
22.0–33.4%),
42.9%
34.3–51.8%),
53.1%
45.0–60.9%),
41.4%
CI,
25.5–59.3%),
also
0.001).
Conclusion
Compared
decreased
while
increased,
suggesting
that
population
faster
scope
wider.
Overall,
it’s
crucial
keep
implementing
comprehensive
measures
like
monitoring
alert
systems,
herd
immunization
plans,
outbreak
control.
International Journal of Hygiene and Environmental Health,
Journal Year:
2024,
Volume and Issue:
259, P. 114382 - 114382
Published: April 22, 2024
Air
pollution
is
a
known
risk
factor
for
several
diseases,
but
the
extent
to
which
it
influences
COVID-19
compared
other
respiratory
diseases
remains
unclear.
We
performed
test-negative
case-control
study
among
people
with
COVID-19-compatible
symptoms
who
were
tested
SARS-CoV-2
infection,
assess
whether
their
long-
and
short-term
exposure
ambient
air
(AAP)
was
associated
testing
positive
(vs.
negative)
SARS-CoV-2.
used
individual-level
data
all
adult
residents
in
Netherlands
between
June
November
2020,
when
only
symptomatic
tested,
modeled
concentrations
of
PM10,
PM2.5,
NO2
O3
at
geocoded
residential
addresses.
In
long-term
analysis,
we
selected
individuals
did
not
change
address
2017–2019
(1.7
million
tests)
considered
average
PM2.5
that
period,
different
sources
PM
(industry,
livestock,
agricultural
activities,
road
traffic,
Dutch
sources,
foreign
sources).
changing
two
weeks
before
day
(2.7
included
analyses,
thus
considering
1-
2-week
as
exposure.
Mixed-effects
logistic
regression
analysis
adjustment
confounders,
including
municipality
week
account
spatiotemporal
variation
viral
circulation,
used.
Overall,
there
no
statistically
significant
effect
studied
pollutants
on
odds
vs.
negative
However,
associations
PM10
from
specifically
livestock
observed.
Short-term
(adjusting
NO2)
also
positively
increased
While
these
exposures
seemed
increase
relative
underlying
biological
mechanisms
remain
This
reinforces
need
continue
strive
better
quality
support
public
health.